Tumor-specific memory CD8+ T cells are strictly resident in draining lymph nodes during tumorigenesis

[1]  Zhonghui Tang,et al.  The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes , 2022, Cell.

[2]  Li Hu,et al.  Tumor-Specific CD4+ T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4– T Cells , 2022, Frontiers in Immunology.

[3]  Nikhil S. Joshi,et al.  A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response , 2021, Science Immunology.

[4]  A. Regev,et al.  Conventional type I dendric cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes. , 2021, Immunity.

[5]  Kamir J. Hiam,et al.  Systemic dysfunction and plasticity of the immune macroenvironment in cancer models , 2020, Nature Medicine.

[6]  Thomas D. Wu,et al.  Peripheral T cell expansion predicts tumour infiltration and clinical response , 2020, Nature.

[7]  R. Ahmed,et al.  PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection , 2020, Proceedings of the National Academy of Sciences.

[8]  A. Kallies,et al.  Precursor exhausted T cells: key to successful immunotherapy? , 2019, Nature Reviews Immunology.

[9]  G. Freeman,et al.  Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection. , 2019, Immunity.

[10]  M. Philip,et al.  Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections. , 2019, Current opinion in immunology.

[11]  Howard Y. Chang,et al.  Clonal replacement of tumor-specific T cells following PD-1 blockade , 2019, bioRxiv.

[12]  E. Wherry,et al.  CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. , 2019, Annual review of immunology.

[13]  Jianjun Hu,et al.  The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection , 2019, Front. Immunol..

[14]  A. Kamphorst,et al.  CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. , 2018, Annual review of medicine.

[15]  Sean C. Bendall,et al.  Systemic Immunity Is Required for Effective Cancer Immunotherapy , 2017, Cell.

[16]  T. Honjo,et al.  Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity , 2017, Proceedings of the National Academy of Sciences.

[17]  M. Philip,et al.  CD8+ T cell differentiation and dysfunction in cancer , 2016, Nature Reviews Immunology.

[18]  Scott N. Mueller,et al.  Tissue-resident memory T cells: local specialists in immune defence , 2015, Nature Reviews Immunology.

[19]  S. Jameson,et al.  Transcriptional downregulation of S1pr1 is required for establishment of resident memory CD8+ T cells , 2013, Nature Immunology.

[20]  J. Schenkel,et al.  Sensing and alarm function of resident memory CD8+ T cells , 2013, Nature Immunology.

[21]  C. Drake,et al.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.

[22]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.